| Literature DB >> 27193053 |
Li An1, Yingxiang Lin1, Ting Yang2, Lin Hua3,4.
Abstract
BACKGROUND: Currently, the majority of genetic association studies on chronic obstructive pulmonary disease (COPD) risk focused on identifying the individual effects of single nucleotide polymorphisms (SNPs) as well as their interaction effects on the disease. However, conventional genetic studies often use binary disease status as the primary phenotype, but for COPD, many quantitative traits have the potential correlation with the disease status and closely reflect pathological changes.Entities:
Keywords: COPD; Interaction; MDR; Quantitative traits; SNP
Mesh:
Substances:
Year: 2016 PMID: 27193053 PMCID: PMC4870730 DOI: 10.1186/s40246-016-0076-0
Source DB: PubMed Journal: Hum Genomics ISSN: 1473-9542 Impact factor: 4.639
Single marker effects for sixa COPD-related quantitative traits (n = 310 patients)
| Six COPD-related quantitative traits | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FEV1 | FEV1%pre | FVC | FEV1/FVC (%) | BODE | 6MWT | ||||||||||||
| Main effects |
|
| Main effects |
|
| Main effects |
|
| Main effects |
|
| Main effects |
|
| Main effects |
|
|
| SERPINE2 (rs729631) | 0.004 | 0.176 | EPHX1 (rs868966) | 0.048 | 1.000 | EPHX1 (rs868966) | 0.010 | 0.440 | EPHX1 (rs3738040) | 0.005 | 0.220 | SERPINE2 (rs4674841) | 0.008 | 0.352 | EPHX1 (rs3766934) | 0.027 | 1.000 |
| SERPINE2 (rs975278) | 0.016 | 0.704 | EPHX1 (rs2854450) | 0.022 | 0.968 | EPHX1 (rs1877724) | 0.007 | 0.308 | EPHX1 (rs2234922) | 0.019 | 0.836 | SERPINE2 (rs4674841) | 0.045 | 1.000 | |||
| SERPINE2 (rs4674841) | 0.037 | 1.000 | EPHX1 (rs3738040) | 0.023 | 1.000 | EPHX1 (rs2292558) | 0.015 | 0.660 | GSTP1 (rs1138272) | 0.020 | 0.880 | SERPINE2 (rs6734100) | 0.046 | 1.000 | |||
| SERPINE2 (rs17196253) | 0.013 | 0.572 | EPHX1 (rs1877724) | 0.045 | 1.000 | GSTP1 (rs1138272) | 0.028 | 1.000 | SERPINE2 (rs13392495) | 0.025 | 1.000 | ||||||
| SERPINE2 (rs3820766) | 0.029 | 1.000 | SERPINE2 (rs729631) | 2.27E-05 | 0.001 | SERPINE2 (rs729631) | 0.002 | 0.088 | SERPINE2 (rs2118409) | 0.032 | 1.000 | ||||||
| SERPINE2 (rs975278) | 0.035 | 1.000 | GSTP1 (rs36211088) | 0.032 | 1.000 | ||||||||||||
aThere was no significant main effect for MMRC before being corrected by Bonferroni procedure
*p < 0.05 before corrected by Bonferroni procedure; **p after corrected by Bonferroni procedure
The best models identified by QMDR for COPD-related quantitative traits in Chinese Han population (n = 310 patients)
| COPD-related quantitative traits | The best two-way interaction models | T-CV score | CV consistency | Permutated |
|---|---|---|---|---|
| FEV1 | EPHX1(rs2292568)*GSTP1(rs4147581) | 2.6390 | 7/10 | 0.019* |
| FEV1%pre | EPHX1(rs1051741)*TGFB1(rs6957) | 1.9234 | 7/10 | 0.042* |
| FVC | SERPINE2(rs7583463)*TGFB1(rs2241713) | 2.2735 | 8/10 | 0.028* |
| FEV1/FVC (%) | SERPINE2(rs17196253)*SERPINE2(rs6748795) | 0.3566 | 3/10 | NS |
| BODE | SERPINE2(rs4674841)*SERPINE2 (rs6748795) | −0.3295 | 4/10 | NS |
| MMRC | SERPINE2(rs2118409)*SERPINE2 (rs6712954) | 1.467 | 2/10 | NS |
| 6MWT | SERPINE2(rs7583463)*SERPINE2 (rs2118409) | 1.229 | 7/10 | NS |
CV cross-validation, NS not significant
*P value obtained from the 1000 permutation testing
Fig. 1The best gene-gene interaction models for COPD-related quantitative traits using QMDR method. a FEV1. b FEV1%pre. c FVC. d FEV1/FVC (%). e BODE. f MMRC. g 6MWT. For FEV1, FEV1%pre, FVC, FEV1/FVC, and 6MWT, the y-axis represents the mean of the trait and the error bar represents the standard deviation. For BODE and MMRC, the y-axis represents the median of the trait and the error bar represents the quartile interval
The best two-way models identified by QMDR and GMDR for four lung-function-related quantitative traits in Chinese Han population (n = 310 patients + 203 controls)
| COPD-related quantitative traits | The best two-way interaction models based on QMDR | The best two-way interaction models based on GMDR | ||||
|---|---|---|---|---|---|---|
| Gene-gene interaction | CV consistency | Permutated | Gene-gene interaction | CV consistency | Permutated | |
| FEV1 | rs2260863(EPHX1)*rs4147581(GSTP1) | 5/10 | 0.031* | rs3766934(EPHX1)*rs947895(GSTP1) | 3/10 | NS |
| FEV1%pre | rs10151740(EPHX1)*rs1800469(TGFB1) | 2/10 | NS | rs2260863(EPHX1)*rs861442(SERPINE2) | 3/10 | NS |
| FVC | rs7583463(SERPINE2)*rs2241713(TGFB1) | 5/10 | NS | rs6748795(SERPINE2)*rs2241713(TGFB1) | 4/10 | 0.036* |
| FEV1/FVC (%) | rs17196253(SERPINE2)*rs2241713(TGFB1) | 8/10 | 0.027* | rs729631(SERPINE2)*rs2241713(TGFB1) | 2/10 | NS |
CV cross-validation, NS not significant
*P value obtained from the 1000 permutation testing
The best three-way models identified by QMDR for COPD-related quantitative traits in Chinese Han population (n = 310 patients)
| COPD-related quantitative traits | The best three-way interaction models | T-CV score | CV consistency | Permutated |
|---|---|---|---|---|
| FEV1 | rs4147581(GSTP1)*rs2292568(EPHX1)*rs4674843(SERPINE2) | 0.9948 | 3/10 | NS |
| FEV1%pre | rs282254(SERPINE2)*rs6738983(SERPINE2)*rs2241713(TGFB1) | 0.4451 | 3/10 | NS |
| FVC | rs2241715(TGFB1)*rs282254(SERPINE2)*rs6738983(SERPINE2) | −0.2469 | 2/10 | NS |
| FEV1/FVC (%) | rs10191694(SERPINE2)*rs282254(SERPINE2)*rs2241713(TGFB1) | 0.0393 | 4/10 | NS |
| BODE | rs13392495(SERPINE2)*rs2118409(SERPINE2)*rs2234922(EPHX1) | −0.1974 | 2/10 | NS |
| MMRC | rs4147581(GSTP1)*rs2241718(TGFB1)*rs2118409(SERPINE2) | −2.3572 | 2/10 | 0.022* |
| 6MWT | rs4674841(SERPINE2)*rs7583463(SERPINE2)*rs947895(GSTP1) | 0.9901 | 2/10 | NS |
CV cross-validation, NS not significant
*P value obtained from the 1000 permutation testing
The best three-way models identified by QMDR and GMDR for four lung-function-related quantitative traits in Chinese Han population (n = 310 patients + 203 controls)
| COPD-related quantitative traits | The best three-way interaction models based on QMDR | The best three-way interaction models based on GMDR | ||||
|---|---|---|---|---|---|---|
| Gene-gene interactions | CV consistency | Permutated | Gene-gene interactions | CV consistency | Permutated | |
| FEV1 | rs4147581(GSTP1)*rs2260863(EPHX1)*rs6736436(SERPINE2) | 4/10 | NS | rs868966(EPHX1)*rs7583463(SERPINE2)*rs947895(GSTP1) | 4/10 | NS |
| FEV1%pre | rs282254(SERPINE2)*rs6738983(SERPINE2)*rs2241713(TGFB1) | 4/10 | 0.041* | rs282254(SERPINE2)*rs729631(SERPINE2)*rs1051740(EPHX1) | 2/10 | NS |
| FVC | rs2241715(TGFB1)*rs282254(SERPINE2)*rs6738983(SERPINE2) | 2/10 | NS | rs2241713(TGFB1)*rs6748795(SERPINE2)*rs7579646(SERPINE2) | 4/10 | 0.035* |
| FEV1/FVC (%) | rs10191694(SERPINE2)*rs868966(EPHX1)*rs2241713(TGFB1) | 4/10 | NS | rs4674843(SERPINE2)*rs282254(SERPINE2)*rs2241713(TGFB1) | 5/10 | 0.039* |
CV cross-validation, NS not significant
* P value obtained from the 1000 permutation testing
Fig. 2The interaction of four genes in the network using GeneMANIA web tool. The red circles indicate the four genes studied in this paper, and other pink circles indicate the interacted genes in the network acquired from GeneMANIA web tool. The larger size circles indicate the genes with the greater degree in the network